Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. PRAX
PRAX logo

PRAX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PRAX News

Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results

1d agoBenzinga

Praxis Grants Restricted Stock Units to New Employees

5d agoYahoo Finance

Baker Bros. Increases Praxis Stake to 1.94% with $81.38M Purchase

Feb 23 2026Fool

Baker Bros. Advisors Increases Stake in Praxis Precision Medicines

Feb 23 2026NASDAQ.COM

Perceptive Advisors Increases Stake in Praxis Precision Medicines

Feb 22 2026Fool

Perceptive Advisors Acquires 431,432 Shares of Praxis Precision Medicines

Feb 22 2026Yahoo Finance

Perceptive Advisors Increases Stake in Celcuity

Feb 22 2026Yahoo Finance

Perceptive Advisors Increases Stake in Praxis Precision Medicines

Feb 22 2026NASDAQ.COM

Praxis Precision's Price Target Raised to $700 by Truist

Feb 20 2026stocktwits

Praxis Precision Medicines Reports Wider Q4 Loss Than Expected

Feb 20 2026Benzinga

Praxis Precision Medicines Reports Q4 2025 Financials and Strategic Developments

Feb 19 2026Yahoo Finance

Praxis Precision Medicines Reports Q4 Earnings Miss

Feb 19 2026seekingalpha

Praxis Submits Two New Drug Applications for Ulixacaltamide and Relutrigine

Feb 19 2026Newsfilter

Praxis Precision Medicines Set to Announce Q4 Earnings

Feb 18 2026seekingalpha

Cormorant Increases MoonLake Stake Above 6%

Feb 18 2026stocktwits

Affinity Asset Advisors Acquires New Stake in Praxis Precision Medicines

Feb 14 2026Fool